Pristine Surgical is develops a first-of-its-kind, single-use visualization platform for surgical, diagnostic rigid endoscopic procedures.
Pristine Surgical has raised $15.0M in total funding. The most recent round was Series D. The last funding was announced in March 2022.
Pristine Surgical's investors include MedTech Innovator, Ceros Capital Markets.
Pristine Surgical is headquartered in Manchester, United States.
Pristine Surgical is develops a first-of-its-kind, single-use visualization platform for surgical, diagnostic rigid endoscopic procedures.
Pristine Surgical is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pristine Surgical — Funding & Investors." VCBacked, March 2, 2022, https://www.vcbacked.co/company/pristine-surgical. Accessed July 22, 2026.
VCBacked. (2022). Pristine Surgical — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/pristine-surgical
{{cite web |title=Pristine Surgical — Funding & Investors |url=https://www.vcbacked.co/company/pristine-surgical |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated